Skip Navigation LinksHome > February 2012 - Volume 5 - Issue 2 > Clinical Trial Alert
Text sizing:
A
A
A
Nephrology Times:
doi: 10.1097/01.NEP.0000413149.59388.14
Clinical Trial Alert

Clinical Trial Alert

Free Access

The following is a partial list of new clinical trials recently added to the National Institutes of Health's ClinicalTrials.gov online registry. More information on these trials is available at www.clinicaltrials.gov.

Back to Top | Article Outline

• Anemia •

NCT01519947

A Study of the Effect of Altitude

on Mircera (Methoxy Polyethylene

Glycol-Epoetin Beta) Dose

Requirements in Patients with

Chronic Renal Anemia in

Predialysis or Dialysis

Ages eligible for study: 18 years

and older

Sponsors and collaborators:

Hoffman-La Roche

Contact: Genentech

Phone: 888-662-6728 (Reference study

ID ML25754)

E-mail: genentechclinicaltrials@druginfo.com

Back to Top | Article Outline

• Cardiovascular Disease •

NCT01515878

Hemocontrol's Effectiveness on

the Reduction of Cardiovascular

Long-Term Events (HERACLES)

Ages eligible for study: 65 years

and older

Sponsors and collaborators: Azienda

Ospedaliera Universitaria di Bologna

Policlinico S. Orsola Malpighi

Contact: Prof. Antonio Santoro

Phone: +39 051 6362 430

E-mail: antonio.santoro@aosp.bo.it

Back to Top | Article Outline

• Chronic Kidney Disease •

NCT01517841

Barriers to Peritoneal Dialysis

Selection

Ages eligible for study: 18 years

and older

Sponsors and collaborators:

Suma Prakash

Contact: Anna McGrail

E-mail: amcgrail@metrohealth.org

Back to Top | Article Outline

• Chronic Kidney Disease-Mineral and Bone Disorder •

NCT01521494

PA21 Phase II Clinical Study in

Hemodialysis Patients with

Hyperphosphatemia

Ages eligible for study: 20 years and

older

Sponsors and collaborators: Kissei

Pharmaceutical Co.

Contact: Kissei Pharmaceutical Co.

E-mail: rinsyousiken@pharm.kissei.co.jp

Back to Top | Article Outline

• Diabetes •

NCT01512849

A Study to Evaluate the PK/PD

and Safety of TA-7284 in Patients

with Type 2 Diabetes Mellitus Who

Have Moderate Renal Impairment

Ages eligible for study: 40 years

to 79 years

Sponsors and collaborators: Mitsubishi

Tanabe Pharma

Contact: Clinical Trials Information

Desk

E-mail: cti-inq-ml@ml.mt-pharma.co.jp

NCT01524705

Fluctuation Reduction with

Insulin and Glp-1 Added Together

(FLAT-SUGAR)

Ages eligible for study: 40 years

to 75 years

Sponsors and collaborators: University

of Washington, Eli Lilly and Company,

Novo Nordisk, Sanofi-Aventis,

Amylin Pharmaceuticals, Dexcom,

Bayer, Medicomp, University of

Texas, Department of Veterans Affairs,

Biomedical Research Institute of New

Mexico

Contact: Jeffrey L. Probstfield, MD

Phone: 206-616-0292

E-mail: jeffprob@u.washington.edu

Contact: Irl B. Hirsch, MD

Phone: 206-598-4980

E-mail: ihirsch@u.washington.edu

NCT01513746

Eating Disorders in Type 1 Diabetes:

Mechanisms of Comorbidity

Ages eligible for study: 18 years

to 65 years

Sponsors and collaborators: Duke

University, National Institute of

Diabetes and Digestive and Kidney

Diseases

Contact: Rhonda M. Merwin, PhD

Phone: 919-681-7231

E-mail: rhonda.merwin@duke.edu

Back to Top | Article Outline

• Hemodialysis •

NCT01520207

Mannitol: Potential Role in

Hemodialysis Initiation for

Reduction of Intradialytic

Hypotension

Ages eligible for study: 18 years

and older

Sponsors and collaborators: Brigham

and Women's Hospital

Contact: Sushrut S. Waikar, MD,

MPH

Phone: 617-732-8473

E-mail: swaikar@partners.org

Contact: Finnian R. McCausland,

MBBCh

Phone: 617-264-3057

E-mail: fmccausland@partners.org

Back to Top | Article Outline

• Hypertension •

NCT01522430

Study of Catheter-Based Renal

Denervation Therapy in

Hypertension (DEPART)

Ages eligible for study: 18 years

to 85 years

Sponsors and collaborators: Erasme

University Hospital

Contact: Jean-François Argacha, MD

Phone: 33225555214

E-mail: jean.francois.argacha@erasme.ulb.ac.be

NCT01520506

Rapid Renal Sympathetic

Denervation for Resistant

Hypertension (RAPID)

Ages eligible for study: 18 years

to 85 years

Sponsors and collaborators: Maya

Medical, Meditrial Europe

Contact: Monica Tocchi, MD, PhD

Phone: 00393931155344

E-mail: medical@meditrialeurope.com

Back to Top | Article Outline

• Kidney Stones •

NCT01526304

The Role of FGF23, Klotho,

and Sclerostin in Kidney Stone

Formers

Ages eligible for study: 18 years

to 70 years

Sponsors and collaborators: University

of Zurich

Contact: Marian Struker

Phone: +41 (0)44 255 35 45

E-mail: marian.struker@usz.ch

Contact: Nilufar Mohebbi, MD

E-mail: nilufar.mohebbi@usz.ch

NCT01514032

Extracorporeal Shock Wave

Lithotripsy Versus Retrograde

Intrarenal Surgery for the

Treatment of Kidney Stones

Ages eligible for study: 18 years

and older

Sponsors and collaborators: University

of Zurich

Contact: Damian Weber, MD

Phone: +41 44 2555407

E-mail: damian.weber@usz.ch

Contact: Michael Muentener, MD

Phone: +41 44 2555403

E-mail: michael.muentener@usz.ch

Back to Top | Article Outline

• Pharmacokinetics •

NCT01510899

A Study on the Effect of Renal

Impairment on the Pharmacokinetics

of RO4917838

Ages eligible for study: 18 years

to 70 years

Sponsors and collaborators:

Hoffmann-La Roche

Contact: Genentech

Phone: 888-662-6728 (Reference study

ID BP25261)

E-mail: genentechclinicaltrials@druginfo.com

NCT01512667

Pharmacokinetic Assessment of

Single-Dose Odanacatib

(MK-0822) in Subjects with Severe

Renal Insufficiency (MK-0822-067)

Ages eligible for study: 18 years

to 79 years

Sponsors and collaborators: Merck

Contact: Merck

Phone: 888-577-8839

Back to Top | Article Outline

• Transplantation •

NCT01515605

Molecular Biological and

Molecular-Genetic Monitoring

of Therapy After Kidney

Transplantation

Ages eligible for study: 18 years

and older

Sponsors and collaborators:

Odense University Hospital

Contact: Dr. Martin Tepel

Phone: 4565503755

E-mail: mtepel@health.sdu.dk

NCT01517984

Immune Monitoring and CNI

Withdrawal in Low-Risk

Recipients of Kidney

Transplantation

Ages eligible for study: 18 years

and older

Sponsors and collaborators: National

Institute of Allergy and Infectious

Diseases

Contact: Brandy Haydel

Phone: 212-241-0255

E-mail: Brandy.Haydel@mountsinai.org

NCT01524601

The Rosuvastatin in Transplant

Recipients Study (RITA)

Ages eligible for study: 18 years

and older

Sponsors and collaborators:

University of Oslo School of Pharmacy

Contact: Karsten Misdtevdt, MD, PhD

Phone: +472307000, ext. 1894

E-mail: karsten.midtevdt@rikshospitalet.no

NCT01513707

The Effects of Pretransplant

Dialysis Modality on Posttransplant

Events

Ages eligible for study: 20 years

to 70 years

Sponsors and collaborators:

Hayoung Oh, Baxter

Contact: Hayoung Oh

Phone: 82-2-3410-3440

E-mail: hayoung.oh@samsung.com

Contact: Eunkyoung Jung

Phone: 82-70-7014-4164

E-mail: gait77.jung@samsung.com

NCT01525329

Combination Therapy with

5-Fluorouracil and Photodynamic

Therapy for the Treatment of

Posttransplant Premalignant Skin

Disease

Ages eligible for study: 18 years

and older

Sponsors and collaborators:

The Cleveland Clinic,

National Cancer Institute

Contact: Margo Riha, BSN, RN

Phone: 216-445-8616

E-mail: riham@ccf.org

Contact: Sara Lohser, MD

Phone: 216-444-3347

E-mail: lohsers@ccf.org

© 2012 Lippincott Williams & Wilkins, Inc.

Login